Mobile Menu

  • AboutUs_Normal-24 The EyeCRO Approach
    • About Us
    • Careers
    • Location
    • Partners
  • MiDrops MiDROPS™
  • InVivo Models
    • Allergic Conjunctivitis
    • Corneal Sensitivity
    • Corneal Wound Healing
    • Diabetic Keratopathy
    • DL-AAA Retinal Leakage
    • Dry Eye Disease
    • Endotoxin induced Uveitis
    • Experimental Autoimmune Uveitis
    • Geographic Atrophy
    • Inherited Retinal Degenerations
    • Ischemia Reperfusion Injury
    • Laser-induced Choroidal Neovascularization
    • Light Damaged
    • Mitochondrial Neuropathy
    • Optic Nerve Crush
    • Oxygen Induced Retinopathy
    • Retinal Detachment
    • Retinal Vein Occlusion
    • STZ-induced Diabetic Retinopathy
    • VEGF-induced permeability
  • InVitro Capabilities
    • A2E Quantification
    • Bioanalytical Detection
    • Biochemistry
    • Histology
    • Ophthalmic Imaging and Physiology
  • News News
  • ContactUs Contact Us
  • Menu
  • Skip to primary navigation
  • Skip to main content

https://eyecro.com

  • AboutUs_Normal-24 The EyeCRO Approach
    • About Us
    • Careers
    • Location
    • Partners
  • MiDrops MiDROPS™
  • InVivo Models
    • Allergic Conjunctivitis
    • Corneal Sensitivity
    • Corneal Wound Healing
    • Diabetic Keratopathy
    • DL-AAA Retinal Leakage
    • Dry Eye Disease
    • Endotoxin induced Uveitis
    • Experimental Autoimmune Uveitis
    • Geographic Atrophy
    • Inherited Retinal Degenerations
    • Ischemia Reperfusion Injury
    • Laser-induced Choroidal Neovascularization
    • Light Damaged
    • Mitochondrial Neuropathy
    • Optic Nerve Crush
    • Oxygen Induced Retinopathy
    • Retinal Detachment
    • Retinal Vein Occlusion
    • STZ-induced Diabetic Retinopathy
    • VEGF-induced permeability
  • InVitro Capabilities
    • A2E Quantification
    • Bioanalytical Detection
    • Biochemistry
    • Histology
    • Ophthalmic Imaging and Physiology
  • News News
  • ContactUs Contact Us

Preclinical Ophthalmic Contract Research

Diabetic retinopathy

Research points towards new blindness prevention methods in diabetic eye disease

December 7, 2016 //  by stanselb

By combining data on optometry patient's eyes with advanced computational methods, Indiana University researchers have created a virtual tissue model of diabetes in the eye. The results, reported in the journal PLOS Computational Biology, show precisely how a small protein that can both damage or grow blood vessels in the eye causes vision loss and blindness in people with diabetes. The study …

Category: News, Top NewsTag: Diabetic retinopathy, ophthalmic research, Ophthalmology, vision loss

Detecting diabetic eye disease with machine learning

November 30, 2016 //  by stanselb

Diabetic retinopathy — an eye condition that affects people with diabetes — is the fastest growing cause of blindness, with nearly 415 million diabetic patients at risk worldwide. The disease can be treated if detected early, but if not, it can lead to irreversible blindness.  A few years ago, a Google research team began studying whether machine learning could be used to screen for diabetic …

Category: NewsTag: blindness, diabetes, Diabetic retinopathy, ophthalmic, Ophthalmology, research

Intraocular therapy prevents or reverses diabetic retinopathy in mice

June 2, 2016 //  by stanselb

Pathologic changes of the retina caused by diabetes is the leading cause of blindness in working adults. Diabetic retinopathy has no known cure, treatment options are inadequate, and prevention strategies offer limited protection. In the first of its kind, a report in The American Journal of Pathology describes a potential new intraocular treatment based on manipulating the renin angiotensin …

Category: NewsTag: blindness, diabetes, Diabetic retinopathy, ophthalmic research, Ophthalmology, retina, vision loss

SBIR-STTR Success: Charlesson LLC/EYECRO

November 17, 2015 //  by stanselb

Macular Degeneration is the leading cause of blindness and vision loss in people over 50 –and with life expectancies well into the 80s, it is estimated that 1 and 3 elderly individuals will have to deal with this degenerative disease. The remedy? Monthly injections (via needle) into the back of the eye, where the disease lives. Not only does this method come with the possibility of an infection, …

Category: NewsTag: Age-related macular degeneration, Diabetic retinopathy, MiDROPS, Ophthalmology, ophthalmology research, retinal diseases, vision

Retinal function, structure changes in proliferative diabetic retinopathy revealed

October 28, 2015 //  by stanselb

Patients with proliferative diabetic retinopathy (PDR) exhibit marked visual dysfunction and structural changes in both the inner and outer retinal layers, research findings indicate. Retinal function was evaluated using a number of tests, including contrast sensitivity, frequency doubling perimetry (FDP) and photostress testing. And semiautomatically segmented spectral-domain optical coherence …

Category: NewsTag: contrast sensitivity, Diabetic retinopathy, optical tomography, retina, retinal function, retinal pigment epithelium, RPE degeneration, visual dysfunction

New drug candidate is promising therapeutic option for angiogenic retinal diseases

October 20, 2015 //  by stanselb

A research team led by scientists at Beth Israel Deaconess Medical Center (BIDMC) and the University of New Mexico School of Medicine has identified a small molecule that treats animal models of aged macular degeneration (AMD) and retinopathy of prematurity (ROP) by preventing the overgrowth of blood vessels that are characteristic of these two retinal diseases.  The new findings, described in the …

Category: NewsTag: AMD, animal models, Diabetic retinopathy, eye drops, intravitreal injections, loss of vision, photoreceptor cells, retinal diseases, vascular endothelial growth factor, VEGF

Preserving photoreceptor cells following retinal injury: Inhibition of alternate complement pathway revealed

July 30, 2015 //  by stanselb

Retinal detachment can occur as a result of either blunt trauma or as a side effect of a variety of ophthalmic diseases, including diabetic retinopathy, ocular tumors, and age-related macular degeneration.  There is a significant increase in the immune system's 'alternative complement pathway' following retinal detachment, researchers report, adding that this pathway facilitated early …

Category: NewsTag: Age-related macular degeneration, Diabetic retinopathy, eye diseases, Ophthalmology, photoreceptor cells, Retinal detachment

Bio Matters: Family influences led eyecro’s executive into scientific research

June 29, 2015 //  by stanselb

Rafal Farjo, Ph.D. is chief operating officer of both eyecro and Charlesson, which are involved in research to advance treatments for eye disease such as age-related macular degeneration, diabetic retinopathy and ocular inflammation. Far from resisting his family’s interest in all things STEM — science, technology, engineering and math — Farjo embraced it. “I loved it, and I actually started …

Category: NewsTag: Age-related macular degeneration, contract research subsidiary, Diabetic retinopathy, microemulsion, MiDROPS, ocular inflammation, ophthalmic, Ophthalmology

Metformin use associated with reduced risk of developing open-angle glaucoma

June 2, 2015 //  by stanselb

Taking the medication metformin hydrochloride was associated with reduced risk of developing the sight-threatening disease open-angle glaucoma in people with diabetes, according to a study published online by JAMA Ophthalmology. Medications that mimic caloric restriction such as metformin can reduce the risk of some late age-onset disease. It is unknown whether these caloric mimetic drugs …

Category: NewsTag: cataract, Diabetic retinopathy, glaucoma, macular degeneration

New Trial Shows Drugs are Effective for Diabetic Macular Edema

February 26, 2015 //  by stanselb

 Diabetes is a significant risk factor for developing eye diseases. The most common diabetic eye disease and a leading cause of blindness is diabetic retinopathy.  Americans with diabetic retinopathy have diabetic macular edema (DME) in which fluid leaks into the macula, the area of the retina used when looking straight ahead.  Over the past few years, drugs that target VEGF have become a standard …

Category: NewsTag: aflibercept, anti-VEGF, diabetes, Diabetic Macular Edema, Diabetic retinopathy, eye diseases, severe vision loss

  • Go to page 1
  • Go to page 2
  • Go to Next Page »

© 2023 · EyeCRO · All Rights Reserved.